Yonatan Weiss, MD

Catheter displacement in multi-fraction HDR-brachytherapy is a recognized yet poorly quantified concern. This study evaluates the magnitude of these deviations and their impact on biologically-equivalent-dose (EQD2) metrics.

Efficacy, feasibility, and safety of extracranial, single-fraction MR-guided adaptive radiotherapy (SMART-1fx) was reported in the SMART ONE trial (NCT04939246). This work evaluates SMART plan quality relative to RTOG-0813 standards for an expanded cohort.